Offer - Urjas Oil for just ₹ 1 X
Combihale FB 200 Inhaler is a commercial drug that is prescribed in the form of Inhaler. It is typically used for the treatment of Asthma. The alternative uses of Combihale FB 200 Inhaler have also been explained below.
The right dosage of Combihale FB 200 Inhaler depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
The side effects typically associated with Combihale FB 200 Inhaler include Nasopharyngitis, Headache, Back Pain. Apart from the aforementioned side effects, Combihale FB 200 Inhaler can also lead to other problems, which have been listed below. Normally, these side effects of Combihale FB 200 Inhaler are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Combihale FB 200 Inhaler's effect during pregnancy is Moderate and Moderate while nursing. In addition, Combihale FB 200 Inhaler's effects on the liver, heart and kidney are discussed below in the Combihale FB 200 Inhaler related warnings section.
Other conditions have been mentioned below in the Combihale FB 200 Inhaler contraindications section.
Besides this, Combihale FB 200 Inhaler may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Combihale FB 200 Inhaler is safe while driving, and is addiction.
Combihale FB 200 Inhaler is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Combihale FB 200 Inhaler safe for pregnant women?
Combihale FB may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Combihale FB again without your doctor's advice.
Is the use of Combihale FB 200 Inhaler safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Combihale FB. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Combihale FB 200 Inhaler on the Kidneys?
Combihale FB is not harmful for kidneys.
What is the effect of Combihale FB 200 Inhaler on the Liver?
Using Combihale FB does not have any harmful effects on the liver.
What is the effect of Combihale FB 200 Inhaler on the Heart?
Combihale FB may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Combihale FB 200 Inhaler unless your doctor advises you to do so -
Is this Combihale FB 200 Inhaler habit forming or addictive?
No, there is no any evidence that Combihale FB 200 Inhaler is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Combihale FB 200 Inhaler will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but take Combihale FB 200 Inhaler only as per medical advice.
Is it able to treat mental disorders?
No, Combihale FB 200 Inhaler cannot treat any kind of mental disorder.
Interaction between Food and Combihale FB 200 Inhaler
Taking Combihale FB 200 Inhaler with food is safe.
Interaction between Alcohol and Combihale FB 200 Inhaler
Consult your doctor before consuming alcohol while taking Combihale FB 200 Inhaler as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
Product Description [Internet]: SYMBICORT. AstraZeneca